StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) income statement

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.45−0.22 (-13.17%)

Close on Nov 20, 2026Market cap $1.19MP/E –Yield –

See a number that looks wrong?